Literature DB >> 26475340

Comment on Dornoff et al.: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.

Klaus Müller1, Gunther Klautke2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26475340     DOI： 10.1007/s00066-015-0908-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  3 in total

1.  Erratum to: Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.

Authors:  Nicolas Dornoff; Christian Weiß; Franz Rödel; Jens Wagenblast; Shahram Ghanaati; Atefeh Nateghian; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2015-09       Impact factor: 3.621

2.  External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation.

Authors:  Klaus Müller; Guido Henke; Inge Compter; André O von Bueren; Carsten Friedrich; Geert Janssens; Christof M Kramm; Thomas Hundsberger; Frank Paulsen; Rolf-Dieter Kortmann; Isabella Zwiener; Brigitta G Baumert
Journal:  Pract Radiat Oncol       Date:  2014-11-18

3.  External validation of a Cox prognostic model: principles and methods.

Authors:  Patrick Royston; Douglas G Altman
Journal:  BMC Med Res Methodol       Date:  2013-03-06       Impact factor: 4.615
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.